Englebert Financial Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Sell
1,080
-1,122
-51% -$416K 0.41% 46
2026
Q1
$645K Buy
2,202
+241
+12% +$79.2K 0.73% 29
2025
Q4
$687K Buy
+1,961
New +$663K 0.79% 29

Other funds holding ELV

Englebert Financial Advisers's ELV Position: Q2 2026 in Review

Englebert Financial Advisers reduced its Elevance Health (ELV) stake by 51% in Q2 2026, selling an estimated $416K and leaving 1,080 shares worth $418K. The position accounts for 0.41% of the portfolio, ranked #46.

Englebert Financial Advisers first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $687K in Q4 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Englebert Financial Advisers held 1,080 shares of Elevance Health worth $418K as of Q2 2026.
  • Englebert Financial Advisers sold 1,122 Elevance Health shares in Q2 2026, an estimated $416K.
  • Elevance Health made up 0.41% of Englebert Financial Advisers's portfolio in Q2 2026, its #46 holding.
  • Englebert Financial Advisers first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Englebert Financial Advisers's Elevance Health position peaked at $687K in Q4 2025.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Englebert Financial Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.